Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncotarget|September 4, 2018
Correction: Genetically enhanced T lymphocytes and the intensive care unitTiberiu Tat, Huming Li, Catalin-Sorin Constantinescu, et al.
Frontiers in Oncology|July 23, 2020
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?Cristina Turcas, Vlad Moisoiu, Andrei Stefancu, et al.
Journal of Cellular and Molecular Medicine|March 5, 2025
SERS-Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic LeukaemiaAnamaria Bancos, Stefania D Iancu, Vlad Moisoiu, et al.
Frontiers in Bioengineering and Biotechnology|August 9, 2021
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down SyndromeVlad Moisoiu, Valentina Sas, Andrei Stefancu, et al.
Critical Reviews in Clinical Laboratory Sciences|May 27, 2018
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approachesCiprian Tomuleasa, Cristina Selicean, Sonia Cismas, et al.
Cell Death & Disease|January 21, 2018
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expressionDiana Gulei, Lorand Magdo, Ancuta Jurj, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Journal of Clinical Medicine|August 9, 2019
Approach to the Adult Acute Lymphoblastic Leukemia PatientValentina Sas, Vlad Moisoiu, Patric Teodorescu, et al.
International Journal of Nanomedicine|August 27, 2019
SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancerVlad Moisoiu, Andrei Stefancu, Diana Gulei, et al.
Pageof 5